C07D 215/44
With aryl radicals attached to said nitrogen atoms
Official title: with aryl radicals attached to said nitrogen atoms
C07D215/44 (With aryl radicals attached to said nitrogen atoms) appears on 153 US grants and 167 published applications in this corpus.
Search patents in C07D- Granted patents
- 153
- Published applications
- 167
- Assignees
- 155
- Inventors
- 632
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 6 | 0 |
| 1977 | 3 | 0 |
| 1978 | 0 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 4 | 0 |
| 1988 | 4 | 0 |
| 1989 | 3 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 1 |
| 2002 | 2 | 1 |
| 2003 | 2 | 3 |
| 2004 | 4 | 10 |
| 2005 | 0 | 7 |
| 2006 | 6 | 10 |
| 2007 | 7 | 7 |
| 2008 | 2 | 8 |
| 2009 | 2 | 7 |
| 2010 | 2 | 3 |
| 2011 | 4 | 1 |
| 2012 | 4 | 9 |
| 2013 | 3 | 6 |
| 2014 | 5 | 8 |
| 2015 | 7 | 7 |
| 2016 | 5 | 5 |
| 2017 | 4 | 7 |
| 2018 | 4 | 8 |
| 2019 | 5 | 5 |
| 2020 | 6 | 10 |
| 2021 | 6 | 8 |
| 2022 | 4 | 7 |
| 2023 | 4 | 10 |
| 2024 | 5 | 11 |
| 2025 | 5 | 5 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- Compounds and methods for targeting pathogenic blood vessels28 Apr 2026US 12,612,385 B2Atengen, Inc.
- PAPD5 inhibitors and methods of use thereof2 Dec 2025US 12,486,234 B2Children's Medical Center Corporation
- Modulators of mas-related g-protein receptor X2 and related products and methods12 Aug 2025US 12,384,748 B2Escient Pharmaceuticals, Inc.
- Topoisomerase II-alpha inhibitors and methods of treating cancer using the same6 May 2025US 12,291,502 B2The Regents of the University of Colorado, a body corporate
- Methods for determining drug candidates20 Aug 2026US 2026/0245655 A1Mosaiques Diagnostics and Therapeutics AG
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
- Substituted piperidine compound and use thereof1 Jan 2026US 2026/0001843 A1Takeda Pharmaceutical Company Limited
- SOS1 Inhibitor With Pyrido-Fused Six-Membered Ring Structure6 Feb 2025US 2025/0042857 A1Haihe Biopharma Co., Ltd.
- Amine compounds having anti-inflammatory, antifungal, antiparasitic, and anticancer activity30 Jan 2025US 2025/0034139 A1Pharma Cinq, LLC
Most cited
By later US patents
- Substituted 3-cyanoquinolines83US 6,297,258 B1American Cyanamid Company · 2001
- Antagonism of immunostimulatory CpG-oligonucleotides by 4-aminoquinolines and other weak bases61US 6,479,504 B1Georgia State University Research Foundation, Inc. · 2002
- N,N-bis (quinolin-4-yl)-diamine derivatives, their preparation and their use as antimalarials58US 5,736,557 AHoffman-La Roche Inc. · 1998
- Quinoline compounds54US 5,817,674 ARoussel Uclaf · 1998
- Materials for organic electroluminescent devices49US 8,852,756 B2Merck Patent GmbH · 2014